• Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab

    2 monthes ago - By San Diego Biotechnology

    LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, and Ono Pharmaceutical Co., Ltd. , today announced an option and...
    Read more ...